Acquisition of New Technologies and Their Deployment in Products and Services
First written in FY2019. 13 of 21 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「Following the design and validation of prototypes based on customers’ required specifications, as well as the prototyping of the company’s original model and applications for safety certifications, research and development expenses for the consolidated fiscal year amounted to ¥14.033 million.」
The research and development activities described include prototyping the company’s original model and applying for overseas safety certifications in the CTO business. Group-wide research and development expenses were ¥28.363 million. - 2026-08-03AdvancedOther Disclosures
「Through full-scale operations, we aim to enhance corporate value further by generating the following benefits and extending them both within and outside the company.」
The framework for the new institute was defined in greater detail, including the commercialization of research results, expansion into new businesses and integration of software and hardware. - FY2025AdvancedAnnual report
「Total research and development expenses incurred by the Group during the fiscal year were ¥36.342 million.」
Research and development expenses increased from ¥26.754 million in the previous consolidated fiscal year to ¥36.342 million. Work is progressing on liquid-cooled computers, chemical calculations for quantum computers, the HPC-AI Platform, on-premises and cloud integration, and CTO prototypes. - FY2025-H1RestatedAnnual report
「Research and development expenses for the interim consolidated accounting period were ¥13.813 million. There were no material changes in the status of the Group’s research and development activities during the interim consolidated accounting period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥13.813 million for the interim consolidated accounting period. - FY2024AdvancedAnnual report
「Total research and development expenses incurred by the Group during the fiscal year were ¥26.754 million.」
Research and development expenses were ¥26.754 million. The HPC business advanced work on liquid-cooled computers, chemical calculations for quantum computers, the HPC-AI Platform, on-premises and cloud integration, and joint research with university laboratories, while the CTO business worked on the commercialisation of GPU-equipped edge computers. - FY2024-Q3RestatedAnnual report
「Research and development expenses for the third quarter cumulative period were ¥18.936 million. There were no material changes in the status of the Group’s research and development activities during the third quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥18.936 million for the third quarter cumulative period. - FY2024-Q2RestatedAnnual report
「Research and development expenses for the second quarter cumulative period were ¥11.549 million. There were no material changes in the status of the Group’s research and development activities during the second quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥11.549 million for the second quarter cumulative period. - FY2023RestatedAnnual report
「Our research and development activities are aimed at developing products that continue to earn customers’ trust, as before, in order to provide the products and services they seek, as well as acquiring new technologies and deploying them in products and services. Total research and development expenses for the fiscal year were ¥17.409 million.」
The policy of pursuing customer-oriented product development and the deployment of new technologies in the business was maintained, and research and development expenses of ¥17.409 million were disclosed. - FY2023-Q1RestatedAnnual report
「Research and development expenses for the first quarter cumulative period were ¥3.177 million. There were no material changes in the status of our research and development activities during the first quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥3.177 million for the first quarter cumulative period. - FY2022AdvancedAnnual report
「Our research and development activities are aimed at developing products that continue to earn customers’ trust, as before, in order to provide the products and services they seek, as well as acquiring new technologies and deploying them in products and services. As capital investment in the markets in which our HPC and CTO businesses operate is expected to increase, we will continue to conduct research and development activities in each business. Total research and development expenses for the fiscal year were ¥26.375 million.」
Research and development expenses were ¥26.375 million, with specific activities including Fugaku Cloud, chemical calculations for quantum computers, the HPC-AI Platform ver. 2, joint research with university laboratories, and edge computers compatible with local 5G. - FY2022-Q2RestatedAnnual report
「Research and development expenses for the second quarter cumulative period were ¥13.579 million. There were no material changes in the status of our research and development activities during the second quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥13.579 million for the second quarter cumulative period. - FY2022-Q1RestatedAnnual report
「Research and development expenses for the first quarter cumulative period were ¥3.343 million. There were no material changes in the status of our research and development activities during the first quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥3.343 million for the first quarter cumulative period. - FY2021AdvancedAnnual report
「Our research and development activities are aimed at developing products that continue to earn customers’ trust, as before, in order to provide the products and services they seek, as well as acquiring new technologies and deploying them in products and services. As capital investment in the markets in which our HPC and CTO businesses operate is expected to increase, we will continue to conduct research and development activities in each business. Total research and development expenses for the fiscal year were ¥16.603 million.」
Research and development expenses of ¥16.603 million were incurred, with specific activities including Fugaku Cloud, chemical calculations for quantum computers, joint research with universities, and CTO prototype validation. - FY2021-Q3RestatedAnnual report
「Research and development expenses for the third quarter cumulative period were ¥13.382 million. There were no material changes in the status of our research and development activities during the third quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥13.382 million for the third quarter cumulative period. - FY2021-Q2RestatedAnnual report
「Research and development expenses for the second quarter cumulative period were ¥10.100 million. There were no material changes in the status of our research and development activities during the second quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥10.100 million for the second quarter cumulative period. - FY2021-Q1RestatedAnnual report
「Research and development expenses for the first quarter cumulative period were ¥5.225 million. There were no material changes in the status of our research and development activities during the first quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥5.225 million for the first quarter cumulative period. - FY2020AdvancedAnnual report
「Our research and development activities are aimed at developing products that continue to earn customers’ trust, as before, in order to provide the products and services they seek, as well as acquiring new technologies and deploying them in products and services. As capital investment in the markets in which our HPC and CTO businesses operate is expected to increase, we will continue to conduct research and development activities in each business. Total research and development expenses for the fiscal year were ¥11.479 million.」
In addition to the research and development policy, specific activities are described, including MI algorithm development, software evaluation and validation, joint research with university laboratories, and prototype design and validation for the CTO business. - FY2020-Q3RestatedAnnual report
「Research and development expenses for the third quarter cumulative period were ¥9.466 million. There were no material changes in the status of our research and development activities during the third quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥9.466 million for the third quarter cumulative period. - FY2020-Q2RestatedAnnual report
「Research and development expenses for the second quarter cumulative period were ¥6.307 million. There were no material changes in the status of our research and development activities during the second quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and disclosed research and development expenses of ¥6.307 million for the second quarter cumulative period. - FY2020-Q1RestatedAnnual report
「Research and development expenses for the first quarter cumulative period were ¥3.115 million. There were no material changes in the status of our research and development activities during the first quarter cumulative period.」
The company disclosed research and development expenses of ¥3.115 million for the quarter, stating that there were no material changes in its research and development activities. - FY2019First statedAnnual report
「Our research and development activities are aimed at developing products that continue to earn customers’ trust, as before, in order to provide the products and services they seek, as well as acquiring new technologies and deploying them in products and services. We conduct research on an ongoing basis. Total research and development expenses for the fiscal year were ¥14.292 million.」
The objectives of research and development are customer-oriented product development and the commercialisation of new technologies.